Live birth after vitrification of in vitro matured human oocytes

Fertility and Sterility

Volumn 91, Issue 2, 2009, Pages 372-376

  Chian, Ri Cheng ^a   Gilbert, Lucy ^b   Huang, Jack Y J ^a   Demirtas, Ezgi ^a   Holzer, Hananel ^a   Benjamin, Alice ^b   Buckett, William M ^a   Tulandi, Togas ^a   Tan, Seang Lin ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

cryopreservation; fertility preservation; in vitro maturation; live birth; Oocyte; vitrification

Indexed keywords

CLOMIFENE; GONADOTROPIN; LEVOTHYROXINE;

ADULT; ARTICLE; ARTIFICIAL INSEMINATION; CASE REPORT; CELL SURVIVAL; CRYOPRESERVATION; DELIVERY; ECHOGRAPHY; EMBRYO; EMBRYO CULTURE; EMBRYO TRANSFER; EVIDENCE BASED PRACTICE; FEMALE; FEMALE INFERTILITY; FERTILITY; FERTILIZATION IN VITRO; FETUS OUTCOME; FOLLICULAR ASPIRATION; GERMINAL VESICLE; HUMAN; HUMAN CELL; HYPOTHYROIDISM; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; LIVE BIRTH; MENSTRUAL CYCLE; METAPHASE; MULTIPLE CYCLE TREATMENT; OOCYTE MATURATION; OVARY POLYCYSTIC DISEASE; PREGNANCY; PRIORITY JOURNAL; TERTIARY HEALTH CARE; THAWING; TRANSVAGINAL ECHOGRAPHY; UNIVERSITY HOSPITAL; UTERINE TUBE DISEASE; VITRIFICATION;

ADULT; CELL CULTURE TECHNIQUES; CRYOPRESERVATION; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FALLOPIAN TUBE DISEASES; FEMALE; HUMANS; INFANT, NEWBORN; INFERTILITY, FEMALE; LIVE BIRTH; OOCYTE RETRIEVAL; OOCYTES; POLYCYSTIC OVARY SYNDROME; PREGNANCY; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 59249086065     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.11.088     Document Type: Article

References (30)

1. American Cancer Society. Cancer facts and figures 2006 (2006), American Cancer Society, Atlanta, GA
2. Bleyer W. The impact of childhood cancer on the United States and the world. CA Cancer J Clin 40 (1990) 355-367
3. Ries L., Percy C., and Bunin G. Introduction. In: Gurney J., Linet M., Tamra T., Young J., and Bunin G. (Eds). Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995 (NIH Pub No 99-4649) (1999), National Cancer Institute, Bethesda, MD 1-15
4. Rao G.D., Chian R.C., Son W.S., Gilbert L., and Tan S.L. Fertility preservation in women undergoing cancer treatment. Lancet 363 (2004) 1829-1830
5. Huang J.Y., Buckett W.M., Gilbert L., Tan S.L., and Chian R.C. Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy. Gynecol Oncol 105 (2007) 542-544
6. Huang JY, Tulandi T, Holzer H, Tan SL, Chian RC. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril. Published online June 1, 2007.
7. Lee S.J., Schover L.R., Partridge A.H., Patrizio P., Wallace W.H., Hagerty K., et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24 (2006) 2917-2931
8. Ethics Committee of the American Society of Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril 83 (2005) 1622-1628
9. Practice Committee of the American Society of Reproductive Medicine. Ovarian tissue and oocyte cryopreservation. Fertil Steril 82 (2004) 993-998
10. Kuleshova L.L., and Lopata A. Vitrification can be more favorable than slow cooling. Fertil Steril 78 (2002) 449-454
11. Katayama K.P., Stehlik J., Kuwayama M., Kato O., and Stehlik E. High survival rate of vitrified human oocytes results in clinical pregnancy. Fertil Steril 80 (2003) 223-224
12. Kuwayama M., Vajta G., Kato O., and Leibo S.P. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 11 (2005) 300-308
13. Chian R.C., Son W.Y., Huang J.Y.J., Cui S.J., Buckett W.M., and Tan S.L. High survival rates and pregnancies of human oocytes following vitrification: preliminary report. Fertil Steril 84 (2005) S36
14. Lucena E., Bernal D.P., Lucena C., Rojas A., Moran A., and Lucena A. Successful ongoing pregnancies after vitrification of oocytes. Fertil Steril 85 (2006) 108-111
15. Tan S.L., Child T.J., and Gulekli B. In vitro maturation and fertilization of oocytes from unstimulated ovaries: predicting the number of immature oocytes retrieved by early follicular phase ultrasonography. Am J Obstet Gynecol 186 (2002) 684-689
16. Chian R.C., Gulekli B., Buckett W.M., and Tan S.L. Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome. N Engl J Med 341 (1999) 1624-1626
17. Chian R.C., Buckett W.M., Tulandi T., and Tan S.L. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod 15 (2000) 165-170
18. Chian R.C., Buckett W.M., and Tan S.L. In-vitro maturation of human oocytes. Reprod Biomed Online 8 (2004) 148-166
19. Chian R.C., Lim J.H., and Tan S.L. State of the art in in-vitro oocyte maturation. Curr Opin Obstet Gynecol 16 (2004) 211-219
20. Le Du A., Kadoch I.J., Bourcigaux N., Doumerc S., Bourrier M.C., Chevalier N., et al. In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience. Hum Reprod 20 (2005) 420-424
21. Jurema M.W., and Nogueira D. In vitro maturation of human oocytes for assisted reproduction. Fertil Steril 86 (2006) 1277-1291
22. Son W.Y., Chung J.T., Dean N., Lukic J., Holzer H.E., Chian R.C., et al. Comparison of fertilization and embryonic development in sibling mature oocytes retrieved from different follicle sizes on retrieval in IVM cycles. Hum Reprod 22 (2007) i109
23. Centers for Disease Control and Prevention. 2003 Assisted Reproductive Technology (ART) Report: Section 2-ART Cycles Using Fresh, Nondonor Eggs or Embryos. Available at: http://wwwcdcgov/art/art2003/sect2_fig3-13htm#Figure%203. Accessed on October 20, 2007.
24. Andersen A.N., Gianaroli L., Felberbaum R., de Mouzon J., and Nygren K.G. Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. Hum Reprod 21 (2006) 1680-1697
25. Gunby J., and Daya S. Assisted reproductive technologies (ART) in Canada: 2003 results from the Canadian ART Register. Fertil Steril 88 (2007) 550-559
26. Buckett W.M., Chian R.C., Holzer H., Dean N., Usher R., and Tan S.L. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol 110 (2007) 885-891
27. Brinsden P.R., Wada I., Tan S.L., Balen A., and Jacobs H.S. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 102 (1995) 767-772
28. Tan S.L., Maconochie N., Doyle P., Campbell S., Balen A., Bekir J., et al. Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Am J Obstet Gynecol 171 (1994) 513-520
29. Venn A., Watson L., Bruinsma F., Giles G., and Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354 (1999) 1586-1590
30. Venn A., Jones P., Quinn M., and Healy D. Characteristics of ovarian and uterine cancers in a cohort of in vitro fertilization patients. Gynecol Oncol 82 (2001) 64-68